Alligator Bioscience AB

Financial Performance

• Operating profit/loss for the first quarter 2026 was -17.8 MSEK, compared to -43.7 MSEK in the same period 2025.
• Profit for the period was 1.4 MSEK, compared to -8.3 MSEK in Q1 2025.
• Cash and cash equivalents at the end of the period amounted to 33.0 MSEK (28.9 MSEK).
• The exercise of warrants of series TO 14 in March 2026 resulted in gross…